Construction of prognostic prediction model of resectable lung cancer and survival analysis

Yunkui Zhang, R. Zhang, S. Peng
{"title":"Construction of prognostic prediction model of resectable lung cancer and survival analysis","authors":"Yunkui Zhang, R. Zhang, S. Peng","doi":"10.3760/CMA.J.ISSN.1006-9801.2020.01.004","DOIUrl":null,"url":null,"abstract":"Objective \nTo explore the value of the constructed prognostic prediction model of resectable lung cancer in predicting the survival and prognosis of patients. \n \n \nMethods \nA total of 2 267 patients with primary lung cancer in Shanxi Provincial Cancer Hospital from January 2007 to September 2018 were selected. All patients underwent primary lung cancer surgery without a second primary tumor. Gender, age, occupation, tumor site, pathological type, surgical path, surgical method, tumor stage and treatment were selected as the prognostic factors. A Cox proportional hazard model was used to construct a prognostic index (PI) equation to calculate the PI value of each patient. According to the different ranges of PI values, the low-, intermediate- and high-risk prognosis groups were divided, and the survival status of three groups were evaluated. \n \n \nResults \nGender (RR= 0.684, P= 0.001), age (RR= 0.591, P -0.5 was the high-risk group, and the differences of their survival rates were statistically significant (P < 0.05). The 1-, 3-, and 5-year survival rates for the low-, risk groups were 96.8%, 87.0% and 77.9%; the intermediate-risk group were 91.8%, 82.2% and 61.7%; the high-risk group were 86.5%, 61.7% and 50.3%. respectively. \n \n \nConclusion \nThe prognostic prediction model of resectable lung cancer can predict the prognosis risk and the corresponding survival rate of patients with resectable lung cancer, and it can help clinicians to evaluate the prognosis and formulate subsequent treatment plans. \n \n \nKey words: \nLung neoplasms; Thoracic surgical procedures; Prognosis; Models, genetic; Survival analysis","PeriodicalId":9505,"journal":{"name":"肿瘤研究与临床","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"肿瘤研究与临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2020.01.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To explore the value of the constructed prognostic prediction model of resectable lung cancer in predicting the survival and prognosis of patients. Methods A total of 2 267 patients with primary lung cancer in Shanxi Provincial Cancer Hospital from January 2007 to September 2018 were selected. All patients underwent primary lung cancer surgery without a second primary tumor. Gender, age, occupation, tumor site, pathological type, surgical path, surgical method, tumor stage and treatment were selected as the prognostic factors. A Cox proportional hazard model was used to construct a prognostic index (PI) equation to calculate the PI value of each patient. According to the different ranges of PI values, the low-, intermediate- and high-risk prognosis groups were divided, and the survival status of three groups were evaluated. Results Gender (RR= 0.684, P= 0.001), age (RR= 0.591, P -0.5 was the high-risk group, and the differences of their survival rates were statistically significant (P < 0.05). The 1-, 3-, and 5-year survival rates for the low-, risk groups were 96.8%, 87.0% and 77.9%; the intermediate-risk group were 91.8%, 82.2% and 61.7%; the high-risk group were 86.5%, 61.7% and 50.3%. respectively. Conclusion The prognostic prediction model of resectable lung cancer can predict the prognosis risk and the corresponding survival rate of patients with resectable lung cancer, and it can help clinicians to evaluate the prognosis and formulate subsequent treatment plans. Key words: Lung neoplasms; Thoracic surgical procedures; Prognosis; Models, genetic; Survival analysis
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
可切除肺癌预后预测模型的建立及生存分析
目的探讨构建的可切除肺癌预后预测模型在预测患者生存及预后方面的价值。方法选取2007年1月至2018年9月山西省肿瘤医院原发性肺癌患者2 267例。所有患者均行无第二原发肿瘤的原发性肺癌手术。选择性别、年龄、职业、肿瘤部位、病理类型、手术路径、手术方式、肿瘤分期及治疗作为影响预后的因素。采用Cox比例风险模型构建预后指数(PI)方程,计算每位患者的PI值。根据PI值的不同范围分为低、中、高危预后组,评估三组患者的生存状况。结果性别(RR= 0.684, P= 0.001)、年龄(RR= 0.591, P -0.5)为高危组,其生存率差异有统计学意义(P < 0.05)。低危组的1、3、5年生存率分别为96.8%、87.0%和77.9%;中危组分别为91.8%、82.2%和61.7%;高危组分别为86.5%、61.7%和50.3%。分别。结论可切除肺癌预后预测模型可预测可切除肺癌患者的预后风险及相应的生存率,可帮助临床医生评估预后并制定后续治疗方案。关键词:肺肿瘤;胸外科手术;预后;遗传模型;生存分析
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
肿瘤研究与临床
肿瘤研究与临床 Medicine-Oncology
CiteScore
0.10
自引率
0.00%
发文量
7737
期刊介绍:
期刊最新文献
Progress of the relationship between breast cancer and thyroid diseases Analysis of cancer incidence and mortality in registration areas of Shanxi Province in 2014 Expressions of human epidermal growth factor receptor 2 in recurrent patients after radical gastrectomy and its significance Progress of molecular markers related to papillary thyroid carcinoma Significance of changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in neoadjuvant therapy for rectal cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1